You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ZVRA Sale Disclosure
Mcfarlane Neil F. · SEC Form 4 · Filed Oct 13, 2026
Sale
Calculated transaction value
$224.95K
Mcfarlane Neil F. President And CEO
ZVRA
Zevra Therapeutics
ZVRA
Transaction date
Oct 12, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 1 day later
ZVRA daily price context
Close on/before transaction
$11.32
Oct 12, 2026
First close after public filing
$10.23
Oct 14, 2026
Return after filing · so far
+15.84%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,000 shares @ $11.25
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001434647-26-000075
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$224.95K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Zevra Therapeutics, Inc. ZVRA Current | Sale | Oct 12, 2026 | $224.95K |
| Zevra Therapeutics, Inc. ZVRA | Exercise | Oct 10, 2026 | Not reported |
| Zevra Therapeutics, Inc. ZVRA | Exercise | Oct 10, 2026 | $0 |